Cargando…
Preadmission Insulin-Treated Type 2 Diabetes Mellitus Patients Had Increased Mortality in Intensive Care Units
AIM: To explore the clinical outcomes among preadmission insulin-treated type 2 diabetes mellitus (T2DM) in intensive care units (ICU). PATIENTS AND METHODS: In this retrospective observational study, 578 T2DM patients admitted to ICU were recruited from March 2011 to February 2021, which were compo...
Autores principales: | Fan, Rongping, Xie, Lei, Peng, Xuemin, Yu, Bo, Zou, Huajie, Huang, Jiaojiao, Yu, Xuefeng, Wang, Daowen, Yang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325876/ https://www.ncbi.nlm.nih.gov/pubmed/35911502 http://dx.doi.org/10.2147/DMSO.S369152 |
Ejemplares similares
-
Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus
por: Li, Mengni, et al.
Publicado: (2021) -
Some questions about preadmission metformin use and mortality in patients with sepsis and diabetes mellitus
por: Ye, Jiarong, et al.
Publicado: (2019) -
Preadmission predictors of severe COVID-19 in patients with diabetes mellitus
por: Shukla, Alpana P., et al.
Publicado: (2021) -
Effect of preadmission beta‐blockade on mortality in multiple trauma
por: Eriksson, M., et al.
Publicado: (2018) -
Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study
por: Christiansen, Christian Fynbo, et al.
Publicado: (2013)